This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
3ik3
From Proteopedia
(Difference between revisions)
(New page: '''Unreleased structure''' The entry 3ik3 is ON HOLD Authors: Zhou, Tianjun Description: AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Muta...) |
|||
| Line 1: | Line 1: | ||
'''Unreleased structure''' | '''Unreleased structure''' | ||
| - | The entry 3ik3 is ON HOLD | + | The entry 3ik3 is ON HOLD until sometime in the future |
Authors: Zhou, Tianjun | Authors: Zhou, Tianjun | ||
| Line 7: | Line 7: | ||
Description: AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance | Description: AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance | ||
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Aug 19 12:36:28 2009'' |
Revision as of 09:36, 19 August 2009
Unreleased structure
The entry 3ik3 is ON HOLD until sometime in the future
Authors: Zhou, Tianjun
Description: AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
Page seeded by OCA on Wed Aug 19 12:36:28 2009
